Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

Chloe Pek Sang Tang, MBBS, FRACP, Andre La Gerche, Julie McMullen, BSc(Hons) PhDFCSANZ FAHA, Erin Howden, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Isaac Goncalves, MBBS PhDFRACP, Jenny Ooi, Constantine S. Tam, MBBS (Hons), MD

Blood (2019) 134 (Supplement_1): 4301.

https://doi.org/10.1182/blood-2019-129808

Published: 2019

Journal Articles

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

M. Judith Peterschmitt, MD, Selena Freisens, MD, Audrey W Hou, PharmD, Lisa Underhill, MS, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD

Blood (2018) 132 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2018-99-118319

Published: 2018

Journal Articles

ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

Deven V. Parmar, MD, Daniel Byczkowski, Ronald G. Jubin, PhD, Abraham Abuchowski, PhD, Peter Buontempo, MSc, BSc, Gerry Gitlin, Michelle Boro, Hemant K. Misra, PhD

Blood (2015) 126 (23): 1187.

https://doi.org/10.1182/blood.V126.23.1187.1187

Published: 2015

Journal Articles

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

Tara L. Lin, MD, Laura F. Newell, MD, Robert K. Stuart, MD, Laura C. Michaelis, MD, Stephen E. Rubenstein, MD, Helen S. Pentikis, PhD, Timothy Callahan, PhD, Donna Alvarez, Lawrence D. Mayer, PhD, Arthur C. Louie, MD

Blood (2015) 126 (23): 2510.

https://doi.org/10.1182/blood.V126.23.2510.2510

Published: 2015

Journal Articles

Atrial Fibrillation in CLL/SLL Patients on Ibrutinib

Mohammed Farooqui, DO, Janet Valdez, PA-C, Susan Soto, RN, Amanda Bray, RN, Xin Tian, PhD, Adrian Wiestner, MD PhD

Blood (2015) 126 (23): 2933.

https://doi.org/10.1182/blood.V126.23.2933.2933

Published: 2015

Journal Articles

Evaluation Of The Effect Of Idelalisib On The QT/QTc Interval In Healthy Subjects

Feng Jin, PhD, Michelle Robeson, ND, Huafeng Zhou, PhD, Andie Nichols, Srini Ramanathan, PhD

Blood (2013) 122 (21): 5573.

https://doi.org/10.1182/blood.V122.21.5573.5573

Published: 2013

Journal Articles

High-Dose Pomalidomide and Dexamethasone Induce Rapid Responses In Patients With AL Amyloidosis Exposed To Alkylators, Immune Modulatory Drugs, and Proteasome Inhibitors

Giovanni Palladini, MD, Paolo Milani, MD, Marta Vidus Rosin, MD, Andrea Foli, MD, Giampaolo Merlini, MD

Blood (2013) 122 (21): 288.

https://doi.org/10.1182/blood.V122.21.288.288

Published: 2013

Journal Articles

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 3889.

https://doi.org/10.1182/blood.V114.22.3889.3889

Published: 2009

Journal Articles

TG-0054, a Novel and Potent Stem Cell Mobilizer, Displays Excellent PK/PD and Safety Profile in Phase I Trial.

David T. Chung, Li-Wen Chang, Ying-Huey Huang, Cheng-Yuan Tsai, Ching-Hung Hsu, Chi-Hsin R. King, Judy H. Yuan, Chi-Feng Yen, Yu-Mai Chen, Yi Chin Lu, Ming-Chu Hsu, PhD

Blood (2009) 114 (22): 866.

https://doi.org/10.1182/blood.V114.22.866.866

Published: 2009

Journal Articles

Utility of Holter Electrocardiogram Monitoring in Iron over Loaded β Thalassemia and Sickle Cell Disease.

Naveen Qureshi, MD, Kishor Avasarala, MD, Sylvia Titi Singer, MD, Drucilla Foote, PNP, Ekua Hackney-Stephens, PNP, Robert Hagar, MD, Elliott P. Vichinsky, MD

Blood (2004) 104 (11): 3784.

https://doi.org/10.1182/blood.V104.11.3784.3784

Published: 2004

NARROW

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

Atrial Fibrillation in CLL/SLL Patients on Ibrutinib

Evaluation Of The Effect Of Idelalisib On The QT/QTc Interval In Healthy Subjects

High-Dose Pomalidomide and Dexamethasone Induce Rapid Responses In Patients With AL Amyloidosis Exposed To Alkylators, Immune Modulatory Drugs, and Proteasome Inhibitors

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

TG-0054, a Novel and Potent Stem Cell Mobilizer, Displays Excellent PK/PD and Safety Profile in Phase I Trial.

Utility of Holter Electrocardiogram Monitoring in Iron over Loaded β Thalassemia and Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only